Olanzapine as Alternative Therapy for Patients With Haloperidol-Induced Extrapyramidal Symptoms: Results of a Multicenter, Collaborative Trial in Latin America-Reference-Cited by-同舟云学术

Olanzapine as Alternative Therapy for Patients With Haloperidol-Induced Extrapyramidal Symptoms: Results of a Multicenter, Collaborative Trial in Latin America

Published:2001-08 Issue:4 Volume:21 Page:375-381
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:Journal of Clinical Psychopharmacology

Author:

Costa e Silva Jorge A.,Alvarez Nelson,Mazzotti Guido,Gattaz Wagner Farid,Ospina Jorge,Larach Veronica,Starkstein Sergio,Oliva Daniel,Cousins Lynne,Tohen Mauricio,Taylor Cindy C.,Wang Jeff,Tran Pierre V.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference32 articles.

1. Causes of Neuroleptic Noncompliance

2. A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients

3. Extrapyramidal reactions in Asians

4. Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eating cognitions, emotions and behaviour under treatment with second generation antipsychotics: A systematic review and meta-analysis;Journal of Psychiatric Research;2023-04

2. The association of antidepressant monotherapy and weight change in a Middle Eastern psychiatric population;International Clinical Psychopharmacology;2020-03-16

3. Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review;Human Psychopharmacology: Clinical and Experimental;2017-08-15

4. Modelling olanzapine-induced weight gain in rats;The International Journal of Neuropsychopharmacology;2013-10-08

5. Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations;CNS Drugs;2013-07